Ligand id: 9195

Name: clazakizumab

No information available.
Summary of Clinical Use
Phase 2 clinical trials in patients with active rheumatoid arthritis (NCT01373151, results reported in [6]), psoriatic arthritis (NCT01490450, results in [5]), cachexia resulting from non-small cell lung cancer [1,4], acute graft versus host disease (GvHD) and oral mucositis caused by head and neck cancer have been completed. Click here to link to's list of clazakizumab (ALD518 and BMS-945429) trials.